Insect Cell Culture Market Report 2026

The insect cell culture market size has grown rapidly in recent years. It will grow from $1.97 billion in 2025 to $2.18 billion in 2026 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to growth in recombinant protein research, increasing use of baculovirus expression systems, expansion of academic life science research, rising adoption of insect cells in virology studies, availability of advanced culture reagents.

The insect cell culture market size is expected to see rapid growth in the next few years. It will grow to $3.24 billion in 2030 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to increasing demand for viral vector production, expansion of gene therapy pipelines, rising investments in biopharmaceutical manufacturing, growing focus on scalable cell culture systems, increasing adoption of automated culture platforms. Major trends in the forecast period include increasing adoption of serum-free insect cell culture media, rising use of insect cells in vaccine production, growing demand for high-yield recombinant protein expression, expansion of scalable bioreactor-based insect cell systems, enhanced focus on process optimization and consistency.

The increasing prevalence of infectious diseases is expected to drive the growth of the insect cell culture market in the coming years. Infectious diseases are conditions caused by microorganisms such as bacteria, viruses, fungi, or parasites that can spread directly or indirectly between individuals, from animals to humans, or through contaminated food, water, or environmental sources. The rise in infectious diseases is largely attributed to increased global travel, which enables faster transmission of pathogens across regions and populations. Insect cell culture supports efforts to address infectious diseases by enabling efficient production of vaccines, viral vectors, and recombinant proteins, offering a safe and scalable platform for the development of preventive and therapeutic solutions. For example, in March 2025, the UK Health Security Agency (UKHSA), a UK-based government organization responsible for public health protection and infectious disease preparedness, reported that tuberculosis cases in England rose by 13% in 2024 to 5,480, up from 4,850 cases in 2023, highlighting a significant year-over-year increase. Consequently, the rising prevalence of infectious diseases is fueling the growth of the insect cell culture market.

Major companies in the insect cell culture market are prioritizing technological advancements, such as single-cell cloning and traceability, to improve product consistency, enhance bioprocessing efficiency, and ensure regulatory compliance for advanced biologics and gene therapy applications. Single-cell cloning and traceability involve isolating individual cells to create genetically uniform cell lines while maintaining comprehensive documentation of cell origin, handling, and history to support reproducibility, quality control, and regulatory requirements. For instance, in June 2023, Expression Systems, a US-based cell culture media company, introduced the sf9 rhabdovirus-free insect cell line with early-access availability for research use. This suspension-grown cell line is optimized for ESF advanced chemically defined insect cell culture medium, achieving rapid growth, over 95% viability, and high cell densities within five days. It is well suited for producing recombinant proteins, adeno-associated viruses (AAVs), and virus-like particles (VLPs), supporting gene therapy and viral vaccine development. The cells are generated through single-cell printing and are supplied with complete protocols, traceability, and regulatory documentation.

In April 2024, Sino Biological Inc., a China-based biotechnology company, acquired SignalChem Biotech Inc. for $48 million. Through this acquisition, Sino Biological aims to enhance its global presence, broaden its portfolio of kinase-related research reagents, and strengthen its capabilities in drug discovery and development support. SignalChem Biotech Inc., based in Canada, specializes in producing bioactive enzymes, signaling proteins, and molecular tools for cancer research, cell signaling studies, and therapeutic development.

Major companies operating in the insect cell culture market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, GE Healthcare, Becton, Dickinson and Company, Corning Incorporated, Lonza Group Ltd., Charles River Laboratories, Sartorius AG, Wuxi Biologics, QIAGEN N.V., Eppendorf AG, Novavax Inc., Takara Bio Inc., GenScript Biotech Corporation, Promega Corporation, HiMedia Laboratories Pvt. Ltd., Cell Culture Company, Trenzyme, Proteogenix.

Asia-Pacific was the largest region in the insect cell culture market in 2025, and it is expected to be the fastest-growing region in the forecast period. The regions covered in the insect cell culture market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the insect cell culture market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the insect cell culture market by increasing costs of imported bioreactors, culture media components, reagents, and laboratory equipment used in research and biopharmaceutical manufacturing. Pharmaceutical and biotechnology companies in North America and Europe are most affected due to reliance on imported specialized consumables, while Asia-Pacific faces higher costs for advanced cell culture equipment. These tariffs are raising operational costs and impacting research budgets. However, they are also encouraging domestic production of media and reagents, regional equipment manufacturing, and localized supply chain development for cell culture technologies.

The insect cell culture market research report is one of a series of new reports that provides insect cell culture market statistics, including insect cell culture industry global market size, regional shares, competitors with a insect cell culture market share, detailed insect cell culture market segments, market trends and opportunities, and any further data you may need to thrive in the insect cell culture industry. This insect cell culture market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Insect cell culture is a laboratory method in which insect-derived cells are cultivated and maintained under controlled conditions outside their natural environment. These cultures offer a flexible platform for the production of recombinant proteins, vaccines, and viral vectors because of their ability to carry out complex post-translational modifications. They are widely applied in research and biopharmaceutical manufacturing, as they efficiently support viral replication and protein expression.

The main product types of insect cell culture include media, reagents, sera, and equipment. Media are nutrient-rich formulations developed to support the growth, maintenance, and productivity of insect cells in laboratory and industrial settings. Key cell types used include S19 (Spodoptera frugiperda), High Five (Trichoplusia ni), Sf21 (Spodoptera frugiperda), and Drosophila Schneider 2 (S2). Major applications span biopharmaceutical manufacturing, gene therapy, tissue culture and engineering, and cytogenetic studies, with primary end-users comprising pharmaceutical and biotechnology companies, academic and research institutes, and contract research organizations.

The insect cell culture market consists of sales of media, reagents, sera, equipment, bioreactors, flasks, incubators, centrifuges, pipettes, filters, culture plates, shakers, and microscopes. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.